Evolution of β-lactamase-mediated cefiderocol resistance

BACKGROUND: Cefiderocol is a novel siderophore β-lactam with improved hydrolytic stability toward β-lactamases, including carbapenemases, achieved by combining structural moieties of two clinically efficient cephalosporins, ceftazidime and cefepime. Consequently, cefiderocol represents a treatment a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fröhlich, Christopher, Sørum, Vidar, Tokuriki, Nobuhiko, Johnsen, Pål Jarle, Samuelsen, Ørjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410664/
https://www.ncbi.nlm.nih.gov/pubmed/35815680
http://dx.doi.org/10.1093/jac/dkac221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410664/
https://www.ncbi.nlm.nih.gov/pubmed/35815680
http://dx.doi.org/10.1093/jac/dkac221

Ejemplares similares